This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: J. Stefan Institute. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Miha Renko: Innovator in Biochemical Research
Introduction
Miha Renko is a notable inventor based in Slovenia. He has made significant contributions to the field of biochemical research, particularly in the study of Staphylococcus aureus autolysin E. His work focuses on understanding the crystal structure of this enzyme, which has implications for developing inhibitors that could be used in medical applications.
Latest Patents
Miha Renko holds a patent titled "Crystal Structure Of Staphylococcus Aureus Autolysin E, Method Of Producing The Crystal And Its Use In Screening Methods." This invention involves the determination and evaluation of the crystal structure of autolysin E (AtlE) of Staphylococcus aureus, or a crystallizable fragment of AtlE. The patent outlines a method for producing a crystal of AtlE and the respective crystallization kit. It also details its use in screening methods for inhibitors of the N-acetylglucosaminidase activity of AtlE, which is crucial for obtaining atomic spatial relationship data and identifying binding compounds through in silico screening.
Career Highlights
Miha Renko is affiliated with the J. Stefan Institute, where he conducts his research. His work has been instrumental in advancing the understanding of bacterial enzymes and their potential applications in medicine. Despite having no patents to his name, his research contributions are noteworthy.
Collaborations
Miha has collaborated with several esteemed colleagues, including Marko Mihelic and Dusan Turk. These collaborations have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Miha Renko is a dedicated inventor whose work in biochemical research has the potential to impact medical science significantly. His focus on the crystal structure of Staphylococcus aureus autolysin E showcases his commitment to innovation in the field.